Charles River Laboratories International, Inc. (CRL) Social Stream
CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 9 | $465 | $324 | $418 | $203.24 | 105.67% |
| 2021-11-16 | 9 | $465 | $324 | $424.111 | $203.24 | 108.67% |
| 2022-01-20 | 8 | $465 | $324 | $424.111 | $203.24 | 108.67% |
| 2022-03-15 | 9 | $465 | $324 | $396.555 | $203.24 | 95.12% |
| 2022-04-06 | 9 | $465 | $350 | $405.625 | $203.24 | 99.58% |
| 2022-04-13 | 10 | $465 | $350 | $402.444 | $203.24 | 98.01% |
| 2022-04-25 | 10 | $465 | $280 | $392.444 | $203.24 | 93.09% |
| 2022-05-10 | 10 | $465 | $280 | $359.111 | $203.24 | 76.69% |
| 2022-06-09 | 11 | $465 | $280 | $351.666 | $203.24 | 73.03% |
| 2022-07-19 | 11 | $465 | $255 | $340.555 | $203.24 | 67.56% |
| 2022-07-27 | 11 | $465 | $255 | $338.333 | $203.24 | 66.47% |
| 2022-08-01 | 11 | $465 | $255 | $335.555 | $203.24 | 65.1% |
| 2022-08-05 | 10 | $465 | $230 | $310.625 | $203.24 | 52.84% |
| 2022-08-13 | 11 | $465 | $230 | $308.125 | $203.24 | 51.61% |
| 2022-08-16 | 11 | $400 | $230 | $287.5 | $203.24 | 41.46% |
The Trend in the Analyst Price Target
Over the past 15 months, CRL's average price target has gone down $79.12.
Over the past 48 weeks, CRL's average upside potential has been 35.13%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-19 | 8 | 465 | 324 | 424.111 | 362.95 | 16.85% |
| 2022-03-30 | 9 | 465 | 350 | 405.625 | 289.86 | 39.94% |
| 2022-04-07 | 10 | 465 | 350 | 402.444 | 302.02 | 33.25% |
| 2022-05-10 | 10 | 465 | 280 | 359.111 | 229.25 | 56.65% |
| 2022-08-16 | 10 | 400 | 230 | 287.500 | 228.12 | 26.03% |
CRL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.55 | 8 | 0 | 3 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
CRL's average broker recommendation rating improved by 0.2 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CHARLES RIVER LABORATORIES INTERNATIONAL INC's average analyst price target is higher than 1824.83% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, CHARLES RIVER LABORATORIES INTERNATIONAL INC's number of analysts covering the stock is greater than 1432.22% of them.
- In the context of stocks in the large market cap category, CHARLES RIVER LABORATORIES INTERNATIONAL INC's upside potential (average analyst target price relative to current price) is greater than 1419.8% of them.
- In terms of how CHARLES RIVER LABORATORIES INTERNATIONAL INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -1029.47% of that group.
Stocks similar to CHARLES RIVER LABORATORIES INTERNATIONAL INC in the Business Services industry regarding analyst recommendations and price targets are ALLE, ZEN, and WDAY.
View All Top Stocks by Price Target
Make investment decisions regarding CRL using the data that counts. Try POWR Ratings for free.